Earlier this week, shares in Bright Minds Biosciences (ticker DRUG) rocketed up more than 2,000% and, despite a slight correction over the past two days, are still up over 1,500% this month. The gain was so appreciable that it even saw the beleaguered, last-man-standing psychedelic ETF, AdvisorShare’s PSIL, gain around 70%. The price action started on Monday, and by Tuesday evening…
